"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Descriptor ID |
D016896
|
MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1997 | 0 | 3 | 3 |
1998 | 0 | 1 | 1 |
1999 | 0 | 4 | 4 |
2000 | 0 | 3 | 3 |
2001 | 0 | 1 | 1 |
2002 | 0 | 3 | 3 |
2003 | 1 | 3 | 4 |
2004 | 0 | 5 | 5 |
2005 | 0 | 6 | 6 |
2006 | 0 | 5 | 5 |
2007 | 1 | 9 | 10 |
2008 | 0 | 1 | 1 |
2009 | 1 | 11 | 12 |
2010 | 0 | 7 | 7 |
2011 | 0 | 4 | 4 |
2012 | 0 | 3 | 3 |
2013 | 0 | 9 | 9 |
2014 | 0 | 4 | 4 |
2015 | 0 | 7 | 7 |
2016 | 0 | 1 | 1 |
2018 | 0 | 3 | 3 |
2019 | 0 | 2 | 2 |
2020 | 0 | 1 | 1 |
2021 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nat Med. 2023 02; 29(2):392-400.
-
Efficacy and safety of dulaglutide 3.0?and 4.5?mg in patients aged?younger than?65 and?65?years or older: Post hoc analysis of the AWARD-11 trial. Diabetes Obes Metab. 2021 10; 23(10):2279-2288.
-
The use of atropine for treatment of amblyopia using the OptumLabs Data Warehouse. J AAPOS. 2021 04; 25(2):107-109.e1.
-
Racial and ethnic differences in patients involved in alcohol-impaired motor vehicle crashes and its related clinical outcomes among various age groups in the U.S. Traffic Inj Prev. 2020; 21(2):115-121.
-
Strain wave elastography in response assessment to neo-adjuvant chemotherapy in patients with locally advanced breast cancer. Br J Radiol. 2019 Jul; 92(1099):20180515.
-
Randomized trial of care management to improve Parkinson disease care quality. Neurology. 2019 04 16; 92(16):e1831-e1842.
-
Early improvement in SHIM scores with Revactin®. Int J Impot Res. 2020 Mar; 32(2):255-256.
-
Sustained quality-of-life improvements over 10 years after deep brain stimulation for dystonia. Mov Disord. 2018 07; 33(7):1160-1167.
-
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98.
-
Frequency of Bevacizumab and Ranibizumab Injections for Diabetic Macular Edema in Medicare Beneficiaries. Ophthalmic Surg Lasers Imaging Retina. 2018 04 01; 49(4):241-244.